{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:02:17Z","timestamp":1792400537447,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province, China","doi-asserted-by":"publisher","award":["ZR2019BA015"],"award-info":[{"award-number":["ZR2019BA015"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejmech.2020.112044","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T21:40:31Z","timestamp":1578433231000},"page":"112044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Artemisinin-derived hybrids and their anticancer activity"],"prefix":"10.1016","volume":"188","author":[{"given":"Feng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112044_bib1","author":"World Health Organization"},{"key":"10.1016\/j.ejmech.2020.112044_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anti-cancer activities: an overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib3","unstructured":"World Health Organization. Latest Global Cancer Data: Cancer Burden Rises to 18.1 Million New Cases and 9.6 Million Cancer Deaths in 2018."},{"key":"10.1016\/j.ejmech.2020.112044_bib4","author":"World Health Organization"},{"key":"10.1016\/j.ejmech.2020.112044_bib5","author":"International Agency for Research on Cancer"},{"key":"10.1016\/j.ejmech.2020.112044_bib6","doi-asserted-by":"crossref","first-page":"111700","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib7","doi-asserted-by":"crossref","first-page":"111587","DOI":"10.1016\/j.ejmech.2019.111587","article-title":"Coumarin-containing hybrids and their anticancer activities","volume":"181","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib8","doi-asserted-by":"crossref","first-page":"10210","DOI":"10.1002\/anie.201601967","article-title":"Artemisinin-a gift from traditional Chinese medicine to the world (Nobel lecture)","volume":"55","author":"Tu","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2020.112044_bib9","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.micpath.2018.03.014","article-title":"Antibacterial mechanism of artemisinin\/beta-cyclodextrins against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"118","author":"Lin","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejmech.2020.112044_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijantimicag.2016.03.018","article-title":"In\u00a0vitro activity of artemisone and artemisinin derivatives against extracellular and intracellular Helicobacter pylori","volume":"48","author":"Sisto","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112044_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1568026619666190304142802","article-title":"Dihydroartemisinin and its analogs: a new class of antitubercular agents","volume":"19","author":"Kalan","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jcm6030030","article-title":"Novel pharmacological activity of artesunate and artemisinin: their potential as anti-tubercular agents","volume":"6","author":"Choi","year":"2017","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.ejmech.2020.112044_bib14","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2020.112044_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1586\/eri.10.166","article-title":"New pathogenic viruses and novel antiviral drugs","volume":"9","author":"Berkhout","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2020.112044_bib16","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","article-title":"Artemisinin as an anticancer drug: recent advances in target profiling and mechanisms of action","volume":"37","author":"Wong","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2020.112044_bib17","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","article-title":"Artemisinin-derived dimers: potent antimalarial and anti-cancer agents","volume":"59","author":"Frohlich","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00044-016-1778-5","article-title":"The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review","volume":"26","author":"Dai","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112044_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CAD.0000000000000697","article-title":"Artemisinin and its derivatives: a potential treatment for leukemia","volume":"30","author":"Lam","year":"2019","journal-title":"Anti Canccer Drugs"},{"key":"10.1016\/j.ejmech.2020.112044_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in\u00a0vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2020.112044_bib21","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/med.21580","article-title":"Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives","volume":"39","author":"Sun","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2020.112044_bib22","article-title":"Artemisinin-derived dimers as potential anticancer agents: current developments, action mechanisms and structure-activity relationships","author":"Zhang","year":"2019","journal-title":"Arch. der Pharm."},{"key":"10.1016\/j.ejmech.2020.112044_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112044_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrids molecules: the privileged scaffolds for various pharmaceuticals","volume":"124","author":"Mishra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/156800909787314020","article-title":"The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate\u2019s activity in cancer cells","volume":"9","author":"Konkimalla","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2020.112044_bib27","first-page":"422","article-title":"Heterocyclic chalcone analogues as potential anticancer agents","volume":"13","author":"Sharma","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1574892809666140819153902","article-title":"Advances in chalcones with anticancer activities","volume":"10","author":"Karthikeyan","year":"2015","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112044_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2017.03.031","article-title":"Synthesis and biological evaluation of novel chalcone derivatives as a new class of microtubule destabilizing agents","volume":"132","author":"Huang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/ardp.201000391","article-title":"Anti-tumor activity of new artemisinin-chalcone hybrids","volume":"344","author":"Xie","year":"2011","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2020.112044_bib31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1248\/cpb.59.984","article-title":"Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach","volume":"59","author":"Xie","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2020.112044_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2014.11.016","article-title":"Synthesis and in\u00a0vitro biological evaluation of dihydroartemisinyl-chalcone esters","volume":"90","author":"Smit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejmech.2016.06.035","article-title":"Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity","volume":"122","author":"Gaur","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2015.07.010","article-title":"Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies","volume":"101","author":"Thakur","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1568026618666180221114515","article-title":"Bis-coumarin derivatives and their biological activities","volume":"18","author":"Ren","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib36","doi-asserted-by":"crossref","first-page":"17415","DOI":"10.1002\/chem.201502543","article-title":"Fluorescent coumarin-artemisinin conjugates as mitochondria-targeting theranostic probes for enhanced anticancer activities","volume":"21","author":"Zhang","year":"2015","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2020.112044_bib37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/molecules21060758","article-title":"Design, synthesis and cytotoxicity of novel dihydroartemisinin-coumarin hybrids via click chemistry","volume":"21","author":"Tan","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112044_bib38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejmech.2018.04.005","article-title":"Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents","volume":"151","author":"Yu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib39","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3390\/molecules24091672","article-title":"Design, synthesis, and mechanism of dihydroartemisinin-coumarin hybrids as potential anti-neuroinflammatory agents","volume":"24","author":"Yu","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112044_bib40","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1039\/c1nj20172g","article-title":"Application of ferrocene and its derivatives in cancer research","volume":"35","author":"Ornelas","year":"2011","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib41","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1021\/om400446y","article-title":"A\u00a0new age for iron: antitumoral ferrocenes","volume":"32","author":"Braga","year":"2013","journal-title":"Organomet"},{"key":"10.1016\/j.ejmech.2020.112044_bib42","doi-asserted-by":"crossref","first-page":"111791","DOI":"10.1016\/j.ejmech.2019.111791","article-title":"Current scenario of ferrocene-containing hybrids for antimalarial activity","volume":"185","author":"Xiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","article-title":"Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells","volume":"75","author":"Reiter","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib45","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/AAC.00893-13","article-title":"Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety","volume":"57","author":"He","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112044_bib46","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.bmc.2013.04.027","article-title":"Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study","volume":"21","author":"Mott","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib47","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1021\/jm060803i","article-title":"Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines","volume":"49","author":"Alagbala","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib48","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/jm030974c","article-title":"Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10\u03b2-(2-hydroxyethyl)deoxoartemisinin","volume":"47","author":"Jayadevan","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib49","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bmc.2008.12.017","article-title":"Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P.\u00a0falciparum malaria parasites and HL-60 cancer cells","volume":"17","author":"Chadwick","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejmech.2018.03.010","article-title":"Synthesis of novel ring-contracted artemisinin dimers with potent anticancer activities","volume":"150","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib51","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0968-0896(97)00079-5","article-title":"Trioxane dimers have potent antimalarial, antiproliferative and antitumor activities in\u00a0vitro","volume":"5","author":"Posner","year":"1997","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","article-title":"A\u00a0review on anticancer potential of bioactive heterocycle quinoline","volume":"97","author":"Afzal","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17460441.2017.1319357","article-title":"An overview of quinoline as a privileged scaffold in cancer drug discovery","volume":"12","author":"Musiol","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112044_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2017.07.033","article-title":"Recent advances (2015-2016) in anticancer hybrids","volume":"142","author":"Kerru","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib55","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00044-017-1868-z","article-title":"Autophagy promotes apoptosis induction through repressed nitric oxide generation in the treatment of human breast cancer MCF-7 cells with L-A03, a dihydroartemisinin derivative","volume":"26","author":"Yao","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112044_bib56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopha.2018.05.093","article-title":"L-A03, a dihydroartemisinin derivative, promotes apoptotic cell death of human breast cancer MCF-7 cells by targeting c-Jun N-terminal kinase","volume":"105","author":"Yao","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2020.112044_bib57","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1248\/cpb.59.1471","article-title":"Discovery of artemisinin-glycolipid hybrids as anti-oral cancer agents","volume":"59","author":"Ricci","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2020.112044_bib58","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmech.2019.06.018","article-title":"Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity","volume":"178","author":"Gour","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejps.2014.01.014","article-title":"Synthesis and in\u00a0vitro biological evaluation of aminoacridines and artemisinin-acridine hybrids","volume":"56","author":"Joubert","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2020.112044_bib60","doi-asserted-by":"crossref","first-page":"19021","DOI":"10.3390\/molecules191119021","article-title":"Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents","volume":"19","author":"Wang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112044_bib61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bmcl.2014.10.048","article-title":"The biological characteristics of a novel camptothecin-artesunate conjugate","volume":"25","author":"Li","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112044_bib62","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ejps.2012.09.019","article-title":"Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in mice","volume":"47","author":"Lombard","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2020.112044_bib63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ardp.201000363","article-title":"The application of tandem aza-Wittig reaction to synthesize artemisinin-guanidine hybrids and their anti-tumor activity","volume":"344","author":"Xie","year":"2011","journal-title":"Arch. der Pharm."},{"key":"10.1016\/j.ejmech.2020.112044_bib64","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2174\/1871520617666171114111721","article-title":"Steroidal anticancer agents: an overview of estradiol-related compounds","volume":"18","author":"Minorics","year":"2018","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib65","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.31965","article-title":"Therapeutic value of steroidal alkaloids in cancer: current trends and future perspectives","volume":"145","author":"Dey","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2020.112044_bib66","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1021\/jm501239f","article-title":"Discovery and development of Galeterone (TOK-001 or VN\/124-1) for the treatment of all stages of prostate cancer","volume":"58","author":"Najr","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib67","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1016\/j.bmc.2017.04.021","article-title":"Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells","volume":"25","author":"Letis","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib68","doi-asserted-by":"crossref","first-page":"61457","DOI":"10.18632\/oncotarget.18390","article-title":"Cytotoxic profiling of artesunic and betulinic acids and their synthetic hybrid compound on neurons and gliomas","volume":"8","author":"Ackermann","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2020.112044_bib69","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1021\/jm100404t","article-title":"Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells","volume":"53","author":"Horwedel","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib70","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsmedchemlett.8b00381","article-title":"Synthesis of artemisinin-estrogen hybrids highly active against HCMV, P.\u00a0falciparum, and cervical and breast cancer","volume":"9","author":"Frohlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112044_bib71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib73","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2020.112044_bib74","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bmcl.2008.11.067","article-title":"Synthesis of 10-substituted triazolyl artemisinins possessing anticancer activity via Huisgen 1,3-dipolar cylcoaddition","volume":"19","author":"Cho","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112044_bib75","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1016\/j.bmcl.2010.05.074","article-title":"Acid-catalyzed synthesis of 10-substituted triazolyl artemisinins and their growth inhibitory activity against various cancer cells","volume":"20","author":"Oh","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112044_bib76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5012\/bkcs.2011.32.2.737","article-title":"Synthesis of 10\u03b2-substituted triazolyl artemisinins and their growth inhibitory activity against various cancer cells","volume":"32","author":"Lee","year":"2011","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112044_bib77","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.2174\/1381612825666190222155700","article-title":"10-Phenyltriazoyl artemisinin is a novel P-glycoprotein inhibitor that suppresses the overexpression and function of P-glycoprotein","volume":"24","author":"Lee","year":"2018","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2020.112044_bib78","first-page":"868","article-title":"Design, synthesis and antiproliferative activities of artemisinin derivatives substituted by N-heterocycles","volume":"50","author":"Zuo","year":"2015","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejmech.2020.112044_bib79","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1039\/C7NJ04271J","article-title":"Synthesis of novel 1,2,3-triazole based artemisinin derivatives and their antiproliferative activity","volume":"42","author":"Kapkoti","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib80","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00044-016-1524-z","article-title":"Synthesis and in\u00a0vitro cytotoxic evaluation of new triazole derivatives based on artemisinin via click chemistry","volume":"25","author":"Binh","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112044_bib81","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.bmc.2017.04.041","article-title":"Synthesis and anticancer activity of novel aza-artemisinin derivatives","volume":"25","author":"Jana","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib82","first-page":"1789","article-title":"Synthesis and cytotoxic evaluation of artemisinin-triazole hybrids","volume":"11","author":"Tien","year":"2016","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2020.112044_bib83","first-page":"3173","article-title":"Synthesis of a novel series of 1,2,3-triazole-containing artemisinin dimers with potent anticancer activity involving Huisgen 1,3-dipolar cycloaddition reaction","volume":"19","author":"Saikia","year":"2011","journal-title":"Synth. Met."},{"key":"10.1016\/j.ejmech.2020.112044_bib84","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejmech.2017.10.023","article-title":"Synthesis, anticancer evaluation and pharmacokinetic study of novel 10-O-phenyl ethers of dihydroartemisinin","volume":"141","author":"Luan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib85","first-page":"3582","article-title":"Design, synthesis and antiproliferative activity in cancer cells of novel dihydropyrazolyl and pyrazolyl artemisinin-phenyl ethers","volume":"43","author":"Wei","year":"2018","journal-title":"China J. Chin. Mater. Med."},{"key":"10.1016\/j.ejmech.2020.112044_bib86","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bmcl.2019.02.021","article-title":"Artemisinin-indole and artemisinin-imidazole hybrids: synthesis, cytotoxic evaluation and reversal effects on multidrug resistance in MCF-7\/ADR cells","volume":"29","author":"Hu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112044_bib87","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejmech.2015.08.035","article-title":"Novel spirobicyclic artemisinin analogues (artemalogues): synthesis and antitumor activities","volume":"103","author":"Liu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib88","first-page":"1800192","article-title":"Anti-proliferative and anti-malarial activities of spiroisoxazoline analogues of artemisinin","volume":"352","author":"Pratap","year":"2019","journal-title":"Arch Pharm Chem Life Sci"},{"key":"10.1016\/j.ejmech.2020.112044_bib89","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2008.08.031","article-title":"Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide","volume":"274","author":"Oh","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2020.112044_bib90","first-page":"123","article-title":"Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines","volume":"33","author":"Gong","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2020.112044_bib91","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2008.09.023","article-title":"Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis","volume":"274","author":"Nakase","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2020.112044_bib92","first-page":"4111","article-title":"Effects of artemisinin dimers on rat breast cancer cells in\u00a0vitro and in\u00a0vivo","volume":"31","author":"Singh","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2020.112044_bib93","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bioorg.2016.03.008","article-title":"Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton","volume":"66","author":"Ha","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib94","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/ijc.24496","article-title":"Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction","volume":"125","author":"Stockwin","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2020.112044_bib95","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/157018009789353446","article-title":"Design, synthesis and antiproliferative activities of artemisinin derivatives containing a substituted piperazine","volume":"6","author":"Yang","year":"2009","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2020.112044_bib96","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.bmcl.2018.05.035","article-title":"Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents","volume":"28","author":"Li","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112044_bib97","first-page":"919","article-title":"Synthesis and cytotoxic evaluation of artemisinin derivatives containing an aminopropanol group","volume":"13","author":"Giang","year":"2018","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2020.112044_bib98","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/jm0303711","article-title":"Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents","volume":"47","author":"Posner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib99","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1021\/acs.jmedchem.6b01247","article-title":"Design, synthesis, and pharmacological evaluation of 2-(2,5-dimethyl-5,6,7,8-tetrahydroquinolin-8-yl)-N-aryl propanamides as novel smoothened (Smo) antagonists","volume":"59","author":"Liu","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib100","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1002\/jps.24407","article-title":"pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model","volume":"104","author":"Zhang","year":"2015","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2020.112044_bib101","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/CAD.0b013e328336f57b","article-title":"Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells","volume":"21","author":"Morrissey","year":"2010","journal-title":"Anti Canccer Drugs"},{"key":"10.1016\/j.ejmech.2020.112044_bib102","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/cmdc.201600594","article-title":"Synthesis of novel hybrids of thymoquinone and artemisinin with high activity and selectivity against colon cancer","volume":"12","author":"Frohlich","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112044_bib103","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules23040841","article-title":"Treatment of multidrug-resistant leukemia cells by novel artemisinin-, egonol-, and thymoquinone-derived hybrid compounds","volume":"23","author":"Gruber","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112044_bib104","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1016\/j.bmcl.2003.08.023","article-title":"Growth inhibition activity of thioacetal artemisinin derivatives against human umbilical vein endothelial cells","volume":"13","author":"Oh","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112044_bib105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejmech.2016.08.015","article-title":"Synthesis and cytotoxicity of novel artemisinin derivatives containing sulfur atoms","volume":"123","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib106","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.6023\/cjoc201409039","article-title":"Synthesis and antitumor effect of artemisone derivatives","volume":"35","author":"Wei","year":"2015","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib107","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/jm020461q","article-title":"Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy","volume":"46","author":"Posner","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib108","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/jm020119d","article-title":"Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer","volume":"46","author":"Jung","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib109","doi-asserted-by":"crossref","first-page":"24334","DOI":"10.1371\/journal.pone.0024334","article-title":"An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities","volume":"6","author":"He","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2020.112044_bib110","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/cmdc.201700600","article-title":"Activities of 11-azaartemisinin and N-sulfonyl derivatives against neospora caninum and comparative cytotoxicities","volume":"12","author":"Harmse","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112044_bib111","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejmech.2018.09.059","article-title":"Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin","volume":"159","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112044_bib112","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.3390\/molecules18032864","article-title":"Synthesis and cytotoxicity of novel 10-substituted dihydroartemisinin derivatives containing N-arylphenyl-ethenesulfonamide groups","volume":"18","author":"Liu","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112044_bib113","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1248\/cpb.c14-00036","article-title":"Synthesis and anticancer activity of novel deoxoartemisinin-glycolipid hybrids","volume":"62","author":"Min","year":"2014","journal-title":"Chem. Pharm. Bull."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420300118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420300118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:09:31Z","timestamp":1759327771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420300118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":113,"alternative-id":["S0223523420300118"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112044","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemisinin-derived hybrids and their anticancer activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112044"}}